{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:26:22Z","timestamp":1774610782989,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Spine J"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00586-019-06003-3","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T06:03:42Z","timestamp":1557986622000},"page":"1837-1845","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Stem cell\/cellular interventions in human spinal cord injury: Is it time to move from guidelines to regulations and legislations? Literature review and Spinal Cord Society position statement"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5519-9609","authenticated-orcid":false,"given":"Harvinder S.","family":"Chhabra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanchan","family":"Sarda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geeta","family":"Jotwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gourie-Devi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erkan","family":"Kaptanoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Charlifue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. L.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kedar","family":"Phadke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,16]]},"reference":[{"key":"6003_CR1","first-page":"1048","volume-title":"ISCoS textbook on comprehensive management of spinal cord injury, first edit","author":"K Sarda","year":"2015","unstructured":"Sarda K, Chhabra HS (2015) Cellular transplantation for human spinal cord injury: an overview. In: Chhabra HS (ed) ISCoS textbook on comprehensive management of spinal cord injury, first edit. Wolters Kluwer(India)Pvt. Ltd., New Delhi, pp 1048\u20131058"},{"key":"6003_CR2","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/jid.2012.77","volume":"132","author":"V Falanga","year":"2012","unstructured":"Falanga V (2012) Stem cells in tissue repair and regeneration. J Investig Dermatol 132:1538\u20131541. \n                    https:\/\/doi.org\/10.1038\/jid.2012.77","journal-title":"J Investig Dermatol"},{"key":"6003_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1172\/JCI40435","volume":"120","author":"I Hyun","year":"2010","unstructured":"Hyun I (2010) The bioethics of stem cell research and therapy. J Clin Investig 120:71\u201375. \n                    https:\/\/doi.org\/10.1172\/JCI40435","journal-title":"J Clin Investig"},{"key":"6003_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/0019-5413.143913","volume":"49","author":"HS Chhabra","year":"2015","unstructured":"Chhabra HS, Sarda K (2015) Stem cell therapy in spinal trauma: does it have scientific validity? Indian J Orthop 49:56\u201371. \n                    https:\/\/doi.org\/10.4103\/0019-5413.143913","journal-title":"Indian J Orthop"},{"key":"6003_CR5","first-page":"57","volume":"25","author":"A Can","year":"2008","unstructured":"Can A (2008) A concise review on the classification and nomenclature of stem cells. Turk J Hematol 25:57\u201359","journal-title":"Turk J Hematol"},{"key":"6003_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/scd.2007.0266","volume":"18","author":"TA Prokhorova","year":"2009","unstructured":"Prokhorova TA, Harkness LM, Frandsen U et al (2009) Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. Stem Cells Dev 18:47\u201354. \n                    https:\/\/doi.org\/10.1089\/scd.2007.0266","journal-title":"Stem Cells Dev"},{"key":"6003_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143\u2013147","journal-title":"Science"},{"key":"6003_CR8","doi-asserted-by":"publisher","first-page":"786475","DOI":"10.1155\/2013\/786475","volume":"2013","author":"J Li","year":"2013","unstructured":"Li J, Lepski G (2013) Cell transplantation for spinal cord injury: a systematic review. Biomed Res Int 2013:786475. \n                    https:\/\/doi.org\/10.1155\/2013\/786475","journal-title":"Biomed Res Int"},{"key":"6003_CR9","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1073\/pnas.0336479100","volume":"100","author":"E Mezey","year":"2003","unstructured":"Mezey E, Key S, Vogelsang G et al (2003) Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci USA 100:1364\u20131369. \n                    https:\/\/doi.org\/10.1073\/pnas.0336479100","journal-title":"Proc Natl Acad Sci USA"},{"key":"6003_CR10","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1126\/science.290.5497.1775","volume":"290","author":"TR Brazelton","year":"2000","unstructured":"Brazelton TR, Rossi FM, Keshet GI, Blau HM (2000) From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290:1775\u20131779","journal-title":"Science"},{"key":"6003_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1590\/0004-282X20140051","volume":"72","author":"ED Mariano","year":"2014","unstructured":"Mariano ED, Batista CM, Barbosa BJAP et al (2014) Current perspectives in stem cell therapy for spinal cord repair in humans: a review of work from the past 10\u00a0years. Arq Neuropsiquiatr 72:451\u2013456","journal-title":"Arq Neuropsiquiatr"},{"key":"6003_CR12","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3109\/14653249.2011.602338","volume":"13","author":"DD Carrade","year":"2011","unstructured":"Carrade DD, Affolter VK, Outerbridge CA et al (2011) Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions. Cytotherapy 13:1180\u20131192. \n                    https:\/\/doi.org\/10.3109\/14653249.2011.602338","journal-title":"Cytotherapy"},{"key":"6003_CR13","first-page":"1025","volume-title":"ISCoS textbook on comprehensive management of spinal cord injury, first","author":"K Sarda","year":"2015","unstructured":"Sarda K, Chhabra HS (2015) Spinal cord injury research: targets for repair. In: Chhabra HS (ed) ISCoS textbook on comprehensive management of spinal cord injury, first. Wolters Kluwer(India)Pvt. Ltd., New Delhi, pp 1025\u20131039"},{"key":"6003_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrn1956","volume":"7","author":"G Yiu","year":"2006","unstructured":"Yiu G, He Z (2006) Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 7:617\u2013627. \n                    https:\/\/doi.org\/10.1038\/nrn1956","journal-title":"Nat Rev Neurosci"},{"key":"6003_CR15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3109\/14653241003615164","volume":"12","author":"M Zurita","year":"2010","unstructured":"Zurita M, Otero L, Aguayo C et al (2010) Cell therapy for spinal cord repair: optimization of biologic scaffolds for survival and neural differentiation of human bone marrow stromal cells. Cytotherapy 12:522\u2013537. \n                    https:\/\/doi.org\/10.3109\/14653241003615164","journal-title":"Cytotherapy"},{"key":"6003_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.09.021","author":"HS Chhabra","year":"2017","unstructured":"Chhabra HS, Sarda K (2017) Clinical translation of stem cell based interventions for spinal cord injury\u2014are we there yet? Adv Drug Deliv Rev. \n                    https:\/\/doi.org\/10.1016\/j.addr.2017.09.021","journal-title":"Adv Drug Deliv Rev"},{"key":"6003_CR17","doi-asserted-by":"publisher","first-page":"e12272","DOI":"10.1371\/journal.pone.0012272","volume":"5","author":"DL Salazar","year":"2010","unstructured":"Salazar DL, Uchida N, Hamers FPT et al (2010) Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PLoS ONE 5:e12272. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0012272","journal-title":"PLoS ONE"},{"key":"6003_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1084-9521(03)00011-9","volume":"14","author":"H Okano","year":"2003","unstructured":"Okano H, Ogawa Y, Nakamura M et al (2003) Transplantation of neural stem cells into the spinal cord after injury. Semin Cell Dev Biol 14:191\u2013198","journal-title":"Semin Cell Dev Biol"},{"key":"6003_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.expneurol.2011.01.007","volume":"229","author":"MD Ziegler","year":"2011","unstructured":"Ziegler MD, Hsu D, Takeoka A et al (2011) Further evidence of olfactory ensheathing glia facilitating axonal regeneration after a complete spinal cord transection. Exp Neurol 229:109\u2013119. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2011.01.007","journal-title":"Exp Neurol"},{"key":"6003_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0361-9230(97)00463-2","volume":"46","author":"A Ram\u00f3n-Cueto","year":"1998","unstructured":"Ram\u00f3n-Cueto A, Avila J (1998) Olfactory ensheathing glia: properties and function. Brain Res Bull 46:175\u2013187","journal-title":"Brain Res Bull"},{"key":"6003_CR21","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1523\/JNEUROSCI.18-16-06176.1998","volume":"18","author":"T Imaizumi","year":"1998","unstructured":"Imaizumi T, Lankford KL, Waxman SG et al (1998) Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord. J Neurosci 18:6176\u20136185","journal-title":"J Neurosci"},{"key":"6003_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/(SICI)1098-1136(200005)30:3<209::AID-GLIA1>3.0.CO;2-8","volume":"30","author":"T Kato","year":"2000","unstructured":"Kato T, Honmou O, Uede T et al (2000) Transplantation of human olfactory ensheathing cells elicits remyelination of demyelinated rat spinal cord. Glia 30:209\u2013218","journal-title":"Glia"},{"key":"6003_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0896-6273(00)80905-8","volume":"25","author":"A Ram\u00f3n-Cueto","year":"2000","unstructured":"Ram\u00f3n-Cueto A, Cordero MI, Santos-Benito FF, Avila J (2000) Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 25:425\u2013435","journal-title":"Neuron"},{"key":"6003_CR24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/B978-0-444-52137-8.00033-4","volume":"109","author":"G Raisman","year":"2012","unstructured":"Raisman G, Barnett SC, Ram\u00f3n-Cueto A (2012) Repair of central nervous system lesions by transplantation of olfactory ensheathing cells. Handb Clin Neurol 109:541\u2013549. \n                    https:\/\/doi.org\/10.1016\/B978-0-444-52137-8.00033-4","journal-title":"Handb Clin Neurol"},{"key":"6003_CR25","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1093\/brain\/awm040","volume":"130","author":"A Toft","year":"2007","unstructured":"Toft A, Scott DT, Barnett SC, Riddell JS (2007) Electrophysiological evidence that olfactory cell transplants improve function after spinal cord injury. Brain 130:970\u2013984. \n                    https:\/\/doi.org\/10.1093\/brain\/awm040","journal-title":"Brain"},{"issue":"Pt 8","key":"6003_CR26","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1093\/brain\/123.8.1581","volume":"123","author":"SC Barnett","year":"2000","unstructured":"Barnett SC, Alexander CL, Iwashita Y et al (2000) Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons. Brain 123(Pt 8):1581\u20131588","journal-title":"Brain"},{"key":"6003_CR27","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1523\/JNEUROSCI.18-10-03803.1998","volume":"18","author":"A Ram\u00f3n-Cueto","year":"1998","unstructured":"Ram\u00f3n-Cueto A, Plant GW, Avila J, Bunge MB (1998) Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J Neurosci 18:3803\u20133815","journal-title":"J Neurosci"},{"key":"6003_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S0006-8993(00)03235-2","volume":"889","author":"J Lu","year":"2001","unstructured":"Lu J, F\u00e9ron F, Ho SM et al (2001) Transplantation of nasal olfactory tissue promotes partial recovery in paraplegic adult rats. Brain Res 889:344\u2013357","journal-title":"Brain Res"},{"key":"6003_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/(SICI)1096-9861(19991101)413:4<495::AID-CNE1>3.0.CO;2-Z","volume":"413","author":"N Weidner","year":"1999","unstructured":"Weidner N, Blesch A, Grill RJ, Tuszynski MH (1999) Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1. J Comp Neurol 413:495\u2013506","journal-title":"J Comp Neurol"},{"key":"6003_CR30","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/glia.20992","volume":"58","author":"H-W Park","year":"2010","unstructured":"Park H-W, Lim M-J, Jung H et al (2010) Human mesenchymal stem cell-derived Schwann cell-like cells exhibit neurotrophic effects, via distinct growth factor production, in a model of spinal cord injury. Glia 58:1118\u20131132. \n                    https:\/\/doi.org\/10.1002\/glia.20992","journal-title":"Glia"},{"key":"6003_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2202-9-21","volume":"9","author":"Y Xu","year":"2008","unstructured":"Xu Y, Liu Z, Liu L et al (2008) Neurospheres from rat adipose-derived stem cells could be induced into functional Schwann cell-like cells in vitro. BMC Neurosci 9:21. \n                    https:\/\/doi.org\/10.1186\/1471-2202-9-21","journal-title":"BMC Neurosci"},{"key":"6003_CR32","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/nprot.2006.422","volume":"1","author":"JA Biernaskie","year":"2006","unstructured":"Biernaskie JA, McKenzie IA, Toma JG, Miller FD (2006) Isolation of skin-derived precursors (SKPs) and differentiation and enrichment of their Schwann cell progeny. Nat Protoc 1:2803\u20132812. \n                    https:\/\/doi.org\/10.1038\/nprot.2006.422","journal-title":"Nat Protoc"},{"key":"6003_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1018557923309","volume":"26","author":"XM Xu","year":"1997","unstructured":"Xu XM, Chen A, Gu\u00e9nard V et al (1997) Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord. J Neurocytol 26:1\u201316","journal-title":"J Neurocytol"},{"key":"6003_CR34","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1523\/JNEUROSCI.2661-13.2014","volume":"34","author":"H Kanno","year":"2014","unstructured":"Kanno H, Pressman Y, Moody A et al (2014) Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury. J Neurosci 34:1838\u20131855. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2661-13.2014","journal-title":"J Neurosci"},{"key":"6003_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neulet.2008.07.041","volume":"443","author":"H Saberi","year":"2008","unstructured":"Saberi H, Moshayedi P, Aghayan H-R et al (2008) Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes. Neurosci Lett 443:46\u201350. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2008.07.041","journal-title":"Neurosci Lett"},{"key":"6003_CR36","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jcyt.2013.03.012","volume":"15","author":"SO Yazdani","year":"2013","unstructured":"Yazdani SO, Hafizi M, Zali A-R et al (2013) Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury. Cytotherapy 15:782\u2013791. \n                    https:\/\/doi.org\/10.1016\/j.jcyt.2013.03.012","journal-title":"Cytotherapy"},{"key":"6003_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/10790268.2006.11753874","volume":"29","author":"C Lima","year":"2006","unstructured":"Lima C, Pratas-Vital J, Escada P et al (2006) Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal Cord Med 29:191\u2013203 (discussion 204\u20136)","journal-title":"J Spinal Cord Med"},{"key":"6003_CR38","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1093\/brain\/awn173","volume":"131","author":"A Mackay-Sim","year":"2008","unstructured":"Mackay-Sim A, F\u00e9ron F, Cochrane J et al (2008) Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 131:2376\u20132386. \n                    https:\/\/doi.org\/10.1093\/brain\/awn173","journal-title":"Brain"},{"key":"6003_CR39","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/sc.2009.54","volume":"47","author":"HS Chhabra","year":"2009","unstructured":"Chhabra HS, Lima C, Sachdeva S et al (2009) Autologous olfactory [corrected] mucosal transplant in chronic spinal cord injury: an Indian Pilot Study. Spinal Cord 47:887\u2013895. \n                    https:\/\/doi.org\/10.1038\/sc.2009.54","journal-title":"Spinal Cord"},{"issue":"Suppl 1","key":"6003_CR40","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.3727\/096368912X633752","volume":"21","author":"X-H Zhou","year":"2012","unstructured":"Zhou X-H, Ning G-Z, Feng S-Q et al (2012) Transplantation of autologous activated Schwann cells in the treatment of spinal cord injury: six cases, more than five years of follow-up. Cell Transplant 21(Suppl 1):S39\u2013S47. \n                    https:\/\/doi.org\/10.3727\/096368912X633752","journal-title":"Cell Transplant"},{"key":"6003_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1006\/exnr.1997.6694","volume":"148","author":"CM Prewitt","year":"1997","unstructured":"Prewitt CM, Niesman IR, Kane CJ, Houl\u00e9 JD (1997) Activated macrophage\/microglial cells can promote the regeneration of sensory axons into the injured spinal cord. Exp Neurol 148:433\u2013443. \n                    https:\/\/doi.org\/10.1006\/exnr.1997.6694","journal-title":"Exp Neurol"},{"key":"6003_CR42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/sc.2009.153","volume":"48","author":"MS Pedram","year":"2010","unstructured":"Pedram MS, Dehghan MM, Soleimani M et al (2010) Transplantation of a combination of autologous neural differentiated and undifferentiated mesenchymal stem cells into injured spinal cord of rats. Spinal Cord 48:457\u2013463. \n                    https:\/\/doi.org\/10.1038\/sc.2009.153","journal-title":"Spinal Cord"},{"key":"6003_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jnr.21098","volume":"85","author":"YI Tarasenko","year":"2007","unstructured":"Tarasenko YI, Gao J, Nie L et al (2007) Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. J Neurosci Res 85:47\u201357. \n                    https:\/\/doi.org\/10.1002\/jnr.21098","journal-title":"J Neurosci Res"},{"key":"6003_CR44","doi-asserted-by":"publisher","first-page":"630932","DOI":"10.1155\/2015\/630932","volume":"2015","author":"JC Shin","year":"2015","unstructured":"Shin JC, Kim KN, Yoo J et al (2015) Clinical trial of human fetal brain-derived neural stem\/progenitor cell transplantation in patients with traumatic cervical spinal cord injury. Neural Plast 2015:630932. \n                    https:\/\/doi.org\/10.1155\/2015\/630932","journal-title":"Neural Plast"},{"key":"6003_CR45","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.stem.2011.04.012","volume":"8","author":"F Bretzner","year":"2011","unstructured":"Bretzner F, Gilbert F, Baylis F, Brownstone RM (2011) Target populations for first-in-human embryonic stem cell research in spinal cord injury. Cell Stem Cell 8:468\u2013475. \n                    https:\/\/doi.org\/10.1016\/j.stem.2011.04.012","journal-title":"Cell Stem Cell"},{"key":"6003_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1479-5876-6-7","volume":"6","author":"KD Deb","year":"2008","unstructured":"Deb KD, Sarda K (2008) Human embryonic stem cells: preclinical perspectives. J Transl Med 6:7","journal-title":"J Transl Med"},{"key":"6003_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2217\/rme.11.77","volume":"6","author":"J Lebkowski","year":"2011","unstructured":"Lebkowski J (2011) GRNOPC1: the world\u2019s first embryonic stem cell-derived therapy. Interview with Jane Lebkowski. Regen Med 6:11\u201313. \n                    https:\/\/doi.org\/10.2217\/rme.11.77","journal-title":"Regen Med"},{"key":"6003_CR48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1479-5876-8-131","volume":"8","author":"A Liras","year":"2010","unstructured":"Liras A (2010) Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects. J Transl Med 8:131. \n                    https:\/\/doi.org\/10.1186\/1479-5876-8-131","journal-title":"J Transl Med"},{"key":"6003_CR49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3171\/spi.2005.3.3.0173","volume":"3","author":"N Knoller","year":"2005","unstructured":"Knoller N, Auerbach G, Fulga V et al (2005) Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. J Neurosurg Spine 3:173\u2013181. \n                    https:\/\/doi.org\/10.3171\/spi.2005.3.3.0173","journal-title":"J Neurosurg Spine"},{"key":"6003_CR50","first-page":"51","volume":"11","author":"H Bansal","year":"2016","unstructured":"Bansal H, Verma P, Agrawal A et al (2016) Autologous bone marrow-derived stem cells in spinal cord injury. J Stem Cells 11:51\u201361","journal-title":"J Stem Cells"},{"key":"6003_CR51","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1227\/NEU.0000000000001056","volume":"78","author":"SK Oh","year":"2016","unstructured":"Oh SK, Choi KH, Yoo JY et al (2016) A phase III clinical trial showing limited efficacy of autologous mesenchymal stem cell therapy for spinal cord injury. Neurosurgery 78:436\u2013447. \n                    https:\/\/doi.org\/10.1227\/NEU.0000000000001056","journal-title":"Neurosurgery"},{"key":"6003_CR52","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jcyt.2016.01.004","volume":"18","author":"HS Satti","year":"2016","unstructured":"Satti HS, Waheed A, Ahmed P et al (2016) Autologous mesenchymal stromal cell transplantation for spinal cord injury: a phase I pilot study. Cytotherapy 18:518\u2013522. \n                    https:\/\/doi.org\/10.1016\/j.jcyt.2016.01.004","journal-title":"Cytotherapy"},{"key":"6003_CR53","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jcyt.2016.05.003","volume":"18","author":"J Vaquero","year":"2016","unstructured":"Vaquero J, Zurita M, Rico MA et al (2016) An approach to personalized cell therapy in chronic complete paraplegia: the Puerta de Hierro phase I\/II clinical trial. Cytotherapy 18:1025\u20131036. \n                    https:\/\/doi.org\/10.1016\/j.jcyt.2016.05.003","journal-title":"Cytotherapy"},{"key":"6003_CR54","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jcyt.2016.12.002","volume":"19","author":"J Vaquero","year":"2017","unstructured":"Vaquero J, Zurita M, Rico MA et al (2017) Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury. Cytotherapy 19:349\u2013359. \n                    https:\/\/doi.org\/10.1016\/j.jcyt.2016.12.002","journal-title":"Cytotherapy"},{"key":"6003_CR55","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/sj.sc.3102010","volume":"45","author":"D Lammertse","year":"2007","unstructured":"Lammertse D, Tuszynski MH, Steeves JD et al (2007) Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design. Spinal Cord 45:232\u2013242. \n                    https:\/\/doi.org\/10.1038\/sj.sc.3102010","journal-title":"Spinal Cord"},{"key":"6003_CR56","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/sj.sc.3102009","volume":"45","author":"MH Tuszynski","year":"2007","unstructured":"Tuszynski MH, Steeves JD, Fawcett JW et al (2007) Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion\/exclusion criteria and ethics. Spinal Cord 45:222\u2013231. \n                    https:\/\/doi.org\/10.1038\/sj.sc.3102009","journal-title":"Spinal Cord"},{"key":"6003_CR57","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/sj.sc.3102008","volume":"45","author":"JD Steeves","year":"2007","unstructured":"Steeves JD, Lammertse D, Curt A et al (2007) Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord 45:206\u2013221. \n                    https:\/\/doi.org\/10.1038\/sj.sc.3102008","journal-title":"Spinal Cord"},{"key":"6003_CR58","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/sj.sc.3102007","volume":"45","author":"JW Fawcett","year":"2007","unstructured":"Fawcett JW, Curt A, Steeves JD et al (2007) Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 45:190\u2013205. \n                    https:\/\/doi.org\/10.1038\/sj.sc.3102007","journal-title":"Spinal Cord"},{"key":"6003_CR59","first-page":"43","volume":"8","author":"A Sharma","year":"2006","unstructured":"Sharma A (2006) Stem cell research in India: emerging scenario and policy concerns. Asian Biotechnol Dev Rev 8:43\u201353","journal-title":"Asian Biotechnol Dev Rev"},{"key":"6003_CR60","unstructured":"MacGregor C, Petersen A, Munsie M (2015) Regulation of unproven stem cell therapies\u2014medicinal product or medical procedure? \n                    http:\/\/www.eurostemcell.org\/commentanalysis\/regulation-unproven-stem-cell-therapies-medicinal-product-or-medical-procedure"},{"key":"6003_CR61","unstructured":"European Medicines Agency\/EMA (2010) Concerns over unregulated medicinal products containing stem cells. 16 April EMA\/763463"},{"key":"6003_CR62","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1089\/scd.2014.0332","volume":"23","author":"M Munsie","year":"2014","unstructured":"Munsie M, Pera M (2014) Regulatory loophole enables unproven autologous cell therapies to thrive in Australia. Stem Cells Dev 23:34\u201338. \n                    https:\/\/doi.org\/10.1089\/scd.2014.0332","journal-title":"Stem Cells Dev"},{"key":"6003_CR63","unstructured":"TGA. Products regulated as biologicals. \n                    https:\/\/www.tga.gov.au\/products-regulated-biologicals\n                    \n                  . Accessed 1 Jan 2015"},{"key":"6003_CR64","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.molmed.2015.02.008","volume":"21","author":"L Turner","year":"2015","unstructured":"Turner L (2015) US stem cell clinics, patient safety, and the FDA. Trends Mol Med 21:271\u2013273. \n                    https:\/\/doi.org\/10.1016\/j.molmed.2015.02.008","journal-title":"Trends Mol Med"},{"key":"6003_CR65","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/488014a","volume":"488","author":"D Cyranoski","year":"2012","unstructured":"Cyranoski D (2012) FDA\u2019s claims over stem cells upheld. Nature 488:14. \n                    https:\/\/doi.org\/10.1038\/488014a","journal-title":"Nature"},{"key":"6003_CR66","volume-title":"Director general","author":"National Guidelines on Stem Cell Research","year":"2013","unstructured":"National Guidelines on Stem Cell Research (2013) Director general. Indian Council of Medical Research, New Delhi"},{"key":"6003_CR67","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/2229-3485.83228","volume":"2","author":"B George","year":"2011","unstructured":"George B (2011) Regulations and guidelines governing stem cell based products: clinical considerations. Perspect Clin Res 2:94\u201399. \n                    https:\/\/doi.org\/10.4103\/2229-3485.83228","journal-title":"Perspect Clin Res"},{"key":"6003_CR68","volume-title":"National guidelines for stem cell research","author":"G Jotwani","year":"2017","unstructured":"Jotwani G, Das SS (2017) National guidelines for stem cell research. Indian Council of Medical Research & Department of Biotechnology, New Delhi"},{"key":"6003_CR69","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/14636778.2014.970269","volume":"33","author":"SS Tiwari","year":"2014","unstructured":"Tiwari SS, Raman S (2014) Governing stem cell therapy in India: regulatory vacuum or jurisdictional ambiguity? New Genet Soc 33:413\u2013433. \n                    https:\/\/doi.org\/10.1080\/14636778.2014.970269","journal-title":"New Genet Soc"},{"key":"6003_CR70","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/434259a","volume":"434","author":"KS Jayaraman","year":"2005","unstructured":"Jayaraman KS (2005) Indian regulations fail to monitor growing stem-cell use in clinics. Nature 434:259. \n                    https:\/\/doi.org\/10.1038\/434259a","journal-title":"Nature"},{"key":"6003_CR71","first-page":"15","volume":"5","author":"SK Pandya","year":"2008","unstructured":"Pandya SK (2008) Stem cell transplantation in India: tall claims, questionable ethics. Indian J Med Ethics 5:15\u201317","journal-title":"Indian J Med Ethics"},{"key":"6003_CR72","doi-asserted-by":"publisher","unstructured":"Sipp D (2009) The rocky road to regulation. Nat Rep Stem Cells 23\u201327. \n                    https:\/\/doi.org\/10.1038\/stemcells.2009.125","DOI":"10.1038\/stemcells.2009.125"},{"key":"6003_CR73","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1353\/ken.0.0305","volume":"20","author":"CB Cohen","year":"2010","unstructured":"Cohen CB, Cohen PJ (2010) International stem cell tourism and the need for effective regulation. Part I: stem cell tourism in Russia and India: clinical research, innovative treatment, or unproven hype? Kennedy Inst Ethics J 20:27\u201349. \n                    https:\/\/doi.org\/10.1353\/ken.0.0305","journal-title":"Kennedy Inst Ethics J"},{"key":"6003_CR74","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2217\/17460751.2.1.75","volume":"2","author":"B Salter","year":"2007","unstructured":"Salter B, Cooper M, Dickins A, Cardo V (2007) Stem cell science in India: emerging economies and the politics of globalization. Regen Med 2:75\u201389. \n                    https:\/\/doi.org\/10.2217\/17460751.2.1.75","journal-title":"Regen Med"},{"key":"6003_CR75","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1741-7015-10-133","volume":"10","author":"T Bubela","year":"2012","unstructured":"Bubela T, Li MD, Hafez M et al (2012) Is belief larger than fact: expectations, optimism and reality for translational stem cell research. BMC Med 10:133. \n                    https:\/\/doi.org\/10.1186\/1741-7015-10-133","journal-title":"BMC Med"},{"key":"6003_CR76","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.stem.2011.05.012","volume":"8","author":"CEP Goldring","year":"2011","unstructured":"Goldring CEP, Duffy PA, Benvenisty N et al (2011) Assessing the safety of stem cell therapeutics. Cell Stem Cell 8:618\u2013628. \n                    https:\/\/doi.org\/10.1016\/j.stem.2011.05.012","journal-title":"Cell Stem Cell"},{"key":"6003_CR77","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.stem.2008.11.009","volume":"3","author":"I Hyun","year":"2008","unstructured":"Hyun I, Lindvall O, Ahrlund-Richter L et al (2008) New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 3:607\u2013609. \n                    https:\/\/doi.org\/10.1016\/j.stem.2008.11.009","journal-title":"Cell Stem Cell"}],"container-title":["European Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-019-06003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00586-019-06003-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-019-06003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T23:15:46Z","timestamp":1589498146000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00586-019-06003-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,16]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["6003"],"URL":"https:\/\/doi.org\/10.1007\/s00586-019-06003-3","relation":{},"ISSN":["0940-6719","1432-0932"],"issn-type":[{"value":"0940-6719","type":"print"},{"value":"1432-0932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,16]]},"assertion":[{"value":"17 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}